Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy

被引：0
|
作者：
Wenjun Jiang
Jiyuan Chen
Chunai Gong
Yuanyuan Wang
Yuan Gao
Yongfang Yuan
机构：
[1] Fudan University,Department of Clinical Pharmacy and Pharmaceutical Management, School of Pharmacy
[2] East China University of Science and Technology,Department of Pharmacy
[3] Shanghai Ninth People’s Hospital,Department of Pharmacy
[4] Shanghai Jiao Tong University School of Medicine,Department of Pharmacy
[5] Changhai Hospital,undefined
[6] Second Military Medical University,undefined
来源：
Journal of Nanobiotechnology | / 18卷
关键词：
Redox-sensitive; Enzalutamide; Graphene quantum dot derivate; Castration-resistant prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sebastian Christoph Schmid
    Alexander Geith
    Alena Böker
    Robert Tauber
    Anna Katharina Seitz
    Markus Kuczyk
    Christoph von Klot
    Jürgen Erich Gschwend
    Axel Stuart Merseburger
    Margitta Retz
    Advances in Therapy, 2014, 31 : 234 - 241
  • [22] Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
    Tucci, Marcello
    Zichi, Clizia
    Buttigliero, Consuelo
    Vignani, Francesca
    Scagliotti, Giorgio V.
    Di Maio, Massimo
    ONCOTARGETS AND THERAPY, 2018, 11 : 7353 - 7368
  • [23] Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
    Rhea, Logan P.
    Gupta, Brinda
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (02) : 107 - 108
  • [24] Castration-Resistant Prostate Cancer: Enzalutamide better than Placebo
    Lorenz, Judith
    Kretschmer, Alexander
    AKTUELLE UROLOGIE, 2019, 50 (01) : 12 - 13
  • [25] Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
    El-Amm, Joelle
    Patel, Nihar
    Freeman, Ashley
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 235 - 245
  • [26] Current Status of Castration-Resistant Prostate Cancer Drug Therapy
    Mao, Yifeng
    Hu, Mingqiu
    Yang, Gaowei
    Gao, Erke
    Chen, Wenbang
    INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY, 2021, 6 (01): : 41 - 49
  • [27] Multifunctional graphene oxide nanoparticles for drug delivery in cancer
    Itoo, Asif Mohd
    Vemula, Sree Lakshmi
    Gupta, Mahima Tejasvni
    Giram, Mahesh Vilasrao
    Kumar, Sangishetty Akhil
    Ghosh, Balaram
    Biswas, Swati
    JOURNAL OF CONTROLLED RELEASE, 2022, 350 : 26 - 59
  • [28] Enzalutamide - a new agent for treatment of castration-resistant prostate cancer
    Wysocki, Piotr J.
    ONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (05): : 186 - 190
  • [29] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [30] COMBINATION OF INDOMETHACIN AND ENZALUTAMIDE TO TREAT CASTRATION-RESISTANT PROSTATE CANCER
    Liu, Chengfei
    Lou, Wei
    Pan, Chong-xian
    Lara, Primo
    Evans, Christopher
    Parikh, Mamta
    White, Ralph deVere
    Dall'Era, Marc
    Gao, Allen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E694 - E694
12345